Table 3.
Marker | (a) marker values and cystatin C at randomisation |
(b) marker values at randomisation and change in cystatin C (randomisation to month 1) |
(c) marker values 1 month after randomisation and change in cystatin C (randomisation to month 1) |
(d) change in marker values (randomisation to month 1) and change in cystatin C (randomisation to month 1) |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
N | Correlation | p | N | Correlation | P | N | Correlation | p | N | Correlation | p-value | |
CD4 (cells/mm3) | 493 | −0.035 | 0.43 | 493 | 0.090 | 0.045 | 488 | −0.060 | 0.18 | 488 | −0.125 | 0.0058 |
Log HIV-RNA (copies/ml) | 493 | 0.116 | 0.0099 | 493 | −0.128 | 0.0044 | 487 | 0.143 | 0.0015 | 487 | 0.277 | <0.0001 |
HDL (mg/dl) | 492 | −0.220 | <0.0001 | 492 | 0.029 | 0.52 | 491 | −0.240 | <0.0001 | 490 | −0.196 | <0.0001 |
LDL (mg/dl) | 493 | −0.040 | 0.37 | 493 | −0.032 | 0.47 | 490 | 0.014 | 0.76 | 490 | −0.016 | 0.72 |
Total Cholesterol (mg/dl) | 493 | 0.029 | 0.51 | 493 | 0.029 | 0.51 | 492 | 0.063 | 0.16 | 492 | −0.093 | 0.040 |
Log triglycerides (mg/dl) | 493 | 0.181 | <0.0001 | 493 | 0.057 | 0.21 | 492 | 0.213 | <0.0001 | 492 | −0.081 | 0.073 |
Log D-dimer (μg/mL) | 490 | 0.124 | 0.0061 | 490 | −0.105 | 0.020 | 493 | 0.168 | 0.0002 | 490 | 0.254 | <0.0001 |
Log prothrombin fragment 1+2 (pmol/L) | 483 | −0.014 | 0.76 | 483 | −0.064 | 0.16 | 489 | −0.005 | 0.91 | 479 | 0.079 | 0.083 |
Log Amyloid A (mg/L) | 493 | 0.046 | 0.31 | 493 | −0.005 | 0.92 | 493 | 0.072 | 0.11 | 493 | 0.148 | 0.0010 |
Log hsCRP (μg/mL) | 493 | 0.085 | 0.089 | 493 | −0.034 | 0.45 | 493 | 0.133 | 0.0030 | 493 | 0.192 | <0.0001 |
Log Amyloid P (μg/mL) | 491 | 0.017 | 0.70 | 491 | −0.029 | 0.52 | 492 | 0.075 | 0.099 | 490 | 0.064 | 0.16 |
Log IL-6 | 492 | 0.255 | <0.0001 | 492 | −0.033 | 0.46 | 491 | 0.285 | <0.0001 | 490 | 0.121 | 0.0072 |